Flerie AB (publ) (STO:FLERIE)
Sweden · Delayed Price · Currency is SEK 13.55
-0.35 (-2.52%)
Nov 2, 2026, 4:13 PM CET
Flerie AB Market Cap
Flerie AB has a market cap or net worth of 1.17 billion as of November 2, 2026. It is the 23,664th most valuable company in the world and the 295th biggest in Sweden. Its market cap has decreased by 62.37% in one year.
Market Cap
1.17B
Enterprise Value
911.25M
Revenue
2.60M
Global Rank
Country Rank
#295 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 11, 2024, Flerie AB's market cap has decreased from 4.11B to 1.17B, a decrease of -71.39%. That is a compound annual growth rate of -40.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 1.17B | -59.50% |
| Dec 30, 2025 | 2.90B | -20.86% |
| Dec 30, 2024 | 3.67B | -10.74% |
| Jun 11, 2024 | 4.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 2.73B |
| Saniona AB | 1.54B |
| Genovis AB (publ.) | 1.46B |
| Medivir AB | 967.26M |
| SynAct Pharma AB | 908.29M |
| Infant Bacterial Therapeutics AB | 885.07M |
| AlzeCure Pharma AB | 882.54M |
| Oncopeptides AB | 661.32M |